Core Scientific (NASDAQ:CORZ – Get Free Report) is expected to post its Q2 2026 results before the market opens on Friday, August 14th. Analysts expect Core Scientific to announce earnings of ($0.02) per share and revenue of $144.8990 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 8:30 AM ET.
Core Scientific (NASDAQ:CORZ – Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The firm had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. On average, analysts expect Core Scientific to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Core Scientific Trading Up 5.6%
Shares of CORZ stock opened at $20.87 on Thursday. The stock has a market capitalization of $6.71 billion, a price-to-earnings ratio of -4.72 and a beta of 5.59. Core Scientific has a 12-month low of $13.14 and a 12-month high of $30.46. The stock’s 50-day moving average price is $24.06 and its 200-day moving average price is $21.00.
Wall Street Analyst Weigh In
Check Out Our Latest Report on CORZ
Insider Activity at Core Scientific
In other news, insider Todd M. Duchene sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $19.97, for a total transaction of $199,700.00. Following the transaction, the insider owned 1,969,101 shares of the company’s stock, valued at approximately $39,322,946.97. The trade was a 0.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last three months, insiders sold 100,000 shares of company stock valued at $2,448,300. 1.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Core Scientific
A number of institutional investors and hedge funds have recently added to or reduced their stakes in CORZ. Allworth Financial LP grew its stake in Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares in the last quarter. Osaic Holdings Inc. raised its stake in shares of Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after acquiring an additional 1,066 shares in the last quarter. State of Wyoming bought a new stake in shares of Core Scientific during the fourth quarter valued at approximately $66,000. Russell Investments Group Ltd. boosted its holdings in shares of Core Scientific by 61.9% in the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock valued at $67,000 after purchasing an additional 1,507 shares during the period. Finally, IFC & Insurance Marketing Inc. purchased a new stake in shares of Core Scientific in the fourth quarter valued at approximately $75,000.
About Core Scientific
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
Featured Stories
- Five stocks we like better than Core Scientific
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
